A dissection of the CD45/side scatter "blast gate"

American Journal of Clinical Pathology

Volumn 137, Issue 5, 2012, Pages 800-804

  Harrington, Alexandra M ^a   Olteanu, Horatiu ^a   Kroft, Steven H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Blast; CD45 side scatter gate; Flow cytometry; Myelodysplastic syndromes; Myeloproliferative neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BASOPHIL; BLAST CELL; CD45 SIDE SCATTER GATING; CELL ISOLATION; CELL POPULATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLUSTER ANALYSIS; CONTROLLED STUDY; ERYTHROID CELL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MONOCYTE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE; METHODOLOGY;

FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES; MYELODYSPLASTIC SYNDROMES;

EID: 84862621107     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPN4G1IZPABRLH     Document Type: Article

References (19)

1. Kroft SH, Karandikar NJ. Flow cytometric analysis of acute leukemias, myelodysplastic syndromes, and myeloproliferative disorders. In: Carey JL III, McCoy JP Jr, Keren DF, eds. Flow Cytometry in Clinical Diagnosis. 4th ed. Chicago, IL: American Society for Clinical Pathology; 2007.
2. Harrington AM, Olteanu H, Kroft SH. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders. Am J Clin Pathol. 2010;134:749-761.
3. Ogata K, Kishikawa Y, Satoh C, et al. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood. 2006;108:1037-1044. (Pubitemid 44154642)
4. Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood. 2003;102:394-403. (Pubitemid 36759682)
5. Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
6. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
7. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540. (Pubitemid 23346202)
8. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci. 1993;677:265-280. (Pubitemid 23161927)
9. Lacombe F, Durrieu F, Briais A, et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 1997;11:1878-1886. (Pubitemid 27485133)
10. Bjornsson S, Wahlstrom S, Norstrom E, et al. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer. Cytometry B Clin Cytom. 2008;74:91-103. (Pubitemid 351578736)
11. Stachurski D, Smith BR, Pozdnyakova O, et al. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res. 2008;32:215-224. (Pubitemid 351215540)
12. van de Loosdrecht AA, Westers TM, Westra AH, et al. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood. 2008;111:1067-1077. (Pubitemid 351213384)
13. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98:979-987.
14. Kussick SJ, Wood BL. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders. Am J Clin Pathol. 2003;120:854-865. (Pubitemid 37486740)
15. Kussick SJ, Fromm JR, Rossini A, et al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol. 2005;124:170-181. (Pubitemid 41060126)
16. Chow KF, Sevilla DW, Colovai AI, et al. Hematogones are markedly decreased in chronic myeloid leukemia: multiparametric flow cytometric analysis. Leuk Lymphoma. 2011;52:680-686.
17. Maftoun-Banankhah S, Maleki A, Karandikar NJ, et al. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes. Am J Clin Pathol. 2008;129:300-308. (Pubitemid 352029321)
18. Truong F, Smith BR, Stachurski D, et al. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study. Leuk Res. 2009;33:1039-1046.
19. Chen W, Karandikar NJ, McKenna RW, et al. Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience. Am J Clin Pathol. 2007;127:39-46. (Pubitemid 46797016)